Toronto foundation doubles funding for Alzheimer’s research

The Globe and Mail
Ivan Semeniuk, Science reporter

Could a simple saliva test provide the biochemical clues needed to make an early diagnosis of Alzheimer’s disease? Could a commonly used medication for controlling blood pressure carry a hidden benefit in slowing the condition? Could a beam of focused sound waves open a temporary passage in the blood-brain barrier, permitting experimental drugs that would otherwise be blocked to get through to their targets?
Read the rest here: